Page last updated: 2024-08-24

atorvastatin and bilirubin

atorvastatin has been researched along with bilirubin in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (33.33)29.6817
2010's5 (55.56)24.3611
2020's1 (11.11)2.80

Authors

AuthorsStudies
Ceppa, P; Indiveri, F; Pelli, N; Setti, M; Toncini, C1
Hsu, M; Morioka, I; Muchova, L; Schröder, H; Stevenson, DK; Vitek, L; Wong, RJ; Zelenka, J1
Ali, F; Boyle, JJ; Hamdulay, SS; Haskard, DO; Kinderlerer, AR; Lidington, EA; Mason, JC; Randi, AM; Soares, MP; Yamaguchi, T1
Augustin, S; Esteban, R; Ezkurdia, N; Genescà, J; Martell, M; Raurell, I; Rodríguez, S1
Elisaf, M; Kei, A; Liberopoulos, E; Tellis, C; Tselepis, A1
Bátai-Konczos, A; Jemnitz, K; Kékesi, O; Kis, E; Szabó, K; Szabó, M; Veres, Z1
Cerne, D; Hallstroem, S; Jürgens, G; Marc, J; Mirjanic-Azaric, B; Rizzo, M; Srdic, S1
Du, M; Wang, Q; Wang, T; Zhu, S1

Trials

2 trial(s) available for atorvastatin and bilirubin

ArticleYear
Effect of switch to the highest dose of rosuvastatin versus add-on-statin fenofibrate versus add-on-statin nicotinic acid/laropiprant on oxidative stress markers in patients with mixed dyslipidemia.
    Cardiovascular therapeutics, 2014, Volume: 32, Issue:4

    Topics: Aged; Apolipoprotein B-100; Atorvastatin; Bilirubin; Biomarkers; Dinoprost; Drug Therapy, Combination; Dyslipidemias; Female; Fenofibrate; Fluorobenzenes; Greece; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Indoles; Lipoproteins, LDL; Male; Middle Aged; Niacin; Oxidative Stress; Prospective Studies; Pyrimidines; Pyrroles; Rosuvastatin Calcium; Simvastatin; Sulfonamides; Time Factors; Treatment Outcome; Uric Acid

2014
[Optimization of long-term hypolipidemia treatment of patients with myocardial infarction in combination with non-alcoholic steatohepatitis].
    Georgian medical news, 2014, Issue:229

    Topics: Atorvastatin; Bilirubin; Fluorobenzenes; Heptanoic Acids; Humans; Hypolipidemic Agents; Lipids; Liver; Middle Aged; Myocardial Infarction; Non-alcoholic Fatty Liver Disease; Pyrimidines; Pyrroles; Rosuvastatin Calcium; Sulfonamides; Transaminases; Triglycerides; Ursodeoxycholic Acid

2014

Other Studies

7 other study(ies) available for atorvastatin and bilirubin

ArticleYear
Autoimmune hepatitis revealed by atorvastatin.
    European journal of gastroenterology & hepatology, 2003, Volume: 15, Issue:8

    Topics: Aged; Alanine Transaminase; Aspartate Aminotransferases; Atorvastatin; Autoimmune Diseases; Bilirubin; Chemical and Drug Induced Liver Injury; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver; Liver Function Tests; Pyrroles

2003
Statin treatment increases formation of carbon monoxide and bilirubin in mice: a novel mechanism of in vivo antioxidant protection.
    Canadian journal of physiology and pharmacology, 2007, Volume: 85, Issue:8

    Topics: Animals; Antioxidants; Atorvastatin; Bilirubin; Carbon Monoxide; Carboxyhemoglobin; Fluorobenzenes; Heme Oxygenase (Decyclizing); Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipid Peroxidation; Liver Function Tests; Mice; Pyrimidines; Pyrroles; Rosuvastatin Calcium; Sulfonamides

2007
Statin-mediated cytoprotection of human vascular endothelial cells: a role for Kruppel-like factor 2-dependent induction of heme oxygenase-1.
    Journal of thrombosis and haemostasis : JTH, 2007, Volume: 5, Issue:12

    Topics: Antioxidants; Atorvastatin; Bilirubin; Biliverdine; Cell Survival; Cells, Cultured; Cytoprotection; Dose-Response Relationship, Drug; Endothelial Cells; Enzyme Induction; Enzyme Inhibitors; Ferritins; Heme Oxygenase-1; Heptanoic Acids; Humans; Hydrogen Peroxide; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Iron Chelating Agents; Kruppel-Like Transcription Factors; Mevalonic Acid; Oxidants; Oxidative Stress; Prenylation; Promoter Regions, Genetic; Protoporphyrins; Pyrroles; Reactive Oxygen Species; RNA Interference; RNA, Messenger; RNA, Small Interfering; Terpenes

2007
The renal effects of droxidopa are maintained in propranolol treated cirrhotic rats.
    Liver international : official journal of the International Association for the Study of the Liver, 2015, Volume: 35, Issue:2

    Topics: Adrenergic beta-Antagonists; Animals; Atorvastatin; Bilirubin; Carbazoles; Carvedilol; Creatinine; Droxidopa; Drug Evaluation, Preclinical; Drug Therapy, Combination; Hemodynamics; Heptanoic Acids; Liver Cirrhosis, Experimental; Mesenteric Artery, Superior; Osmolar Concentration; Portal Pressure; Potassium; Propanolamines; Propranolol; Pyrroles; Rats; Serum Albumin; Sodium; Vascular Resistance

2015
Statins alter the hepatobiliary transport of unconjugated and conjugated bilirubin in sandwich-cultured rat hepatocytes.
    Toxicology in vitro : an international journal published in association with BIBRA, 2014, Volume: 28, Issue:6

    Topics: Animals; Atorvastatin; ATP-Binding Cassette Transporters; Bilirubin; Biological Transport; Cell Culture Techniques; Cells, Cultured; Fatty Acids, Monounsaturated; Fluorobenzenes; Fluvastatin; Hepatocytes; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Multidrug Resistance-Associated Proteins; Organic Anion Transporters; Pravastatin; Pyrimidines; Pyrroles; Rats; Rosuvastatin Calcium; Sulfonamides

2014
Atorvastatin treatment increases plasma bilirubin but not HMOX1 expression in stable angina patients.
    Scandinavian journal of clinical and laboratory investigation, 2015, Volume: 75, Issue:5

    Topics: Angina, Stable; Atorvastatin; Bilirubin; Female; Gene Expression Regulation, Enzymologic; Heme Oxygenase-1; Humans; Male; Middle Aged; Proteolysis; RNA, Messenger

2015
Application of Atorvastatin Combined with Ezetimibe in Elderly Patients with Hypertension Combined with T2DM and Analysis of Significance of Changes in Serum Bilirubin Levels During Treatment.
    Alternative therapies in health and medicine, 2023, Volume: 29, Issue:8

    Topics: Aged; Atorvastatin; Bilirubin; Diabetes Mellitus, Type 2; Ezetimibe; Glucose; Humans; Hypertension

2023